For bile duct carcinoma, it was found that the knockdown of claudin-18 expression or an antibody specific to claudin-18 can significantly attenuate the proliferation, invasion and in vivo tumourigenesis of bile duct adenocarcinoma cells. This evidence concerns the gene CLDN18 and bile duct carcinoma.